IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $52,560 | +14.8% | 1,281 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $45,783 | -5.4% | 1,281 | 0.0% | 0.01% | -10.0% |
| Q4 2022 | $48,383 | -15.1% | 1,281 | 0.0% | 0.01% | -23.1% |
| Q3 2022 | $57,000 | +21.3% | 1,281 | 0.0% | 0.01% | +30.0% |
| Q2 2022 | $47,000 | 0.0% | 1,281 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $47,000 | +20.5% | 1,281 | 0.0% | 0.01% | +12.5% |
| Q4 2021 | $39,000 | -9.3% | 1,281 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $43,000 | -15.7% | 1,281 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $51,000 | -28.2% | 1,281 | -19.0% | 0.01% | -33.3% |
| Q1 2021 | $71,000 | -37.2% | 1,581 | -21.2% | 0.02% | -43.8% |
| Q4 2020 | $113,000 | +18.9% | 2,006 | 0.0% | 0.03% | +6.7% |
| Q3 2020 | $95,000 | -19.5% | 2,006 | 0.0% | 0.03% | -28.6% |
| Q2 2020 | $118,000 | -2.5% | 2,006 | 0.0% | 0.04% | -2.3% |
| Q1 2020 | $121,000 | 0.0% | 2,006 | 0.0% | 0.04% | +2.4% |
| Q4 2019 | $121,000 | +0.8% | 2,006 | 0.0% | 0.04% | -6.7% |
| Q3 2019 | $120,000 | +2.6% | 2,006 | +9.9% | 0.04% | +2.3% |
| Q2 2019 | $117,000 | -20.9% | 1,825 | 0.0% | 0.04% | -27.9% |
| Q1 2019 | $148,000 | +43.7% | 1,825 | -3.9% | 0.06% | +27.1% |
| Q4 2018 | $103,000 | +5.1% | 1,900 | 0.0% | 0.05% | +20.0% |
| Q3 2018 | $98,000 | +24.1% | 1,900 | 0.0% | 0.04% | +14.3% |
| Q2 2018 | $79,000 | -6.0% | 1,900 | 0.0% | 0.04% | 0.0% |
| Q1 2018 | $84,000 | -12.5% | 1,900 | 0.0% | 0.04% | -7.9% |
| Q4 2017 | $96,000 | 0.0% | 1,900 | 0.0% | 0.04% | -5.0% |
| Q3 2017 | $96,000 | -1.0% | 1,900 | 0.0% | 0.04% | -9.1% |
| Q2 2017 | $97,000 | +27.6% | 1,900 | 0.0% | 0.04% | +22.2% |
| Q1 2017 | $76,000 | -16.5% | 1,900 | 0.0% | 0.04% | -20.0% |
| Q4 2016 | $91,000 | +30.0% | 1,900 | 0.0% | 0.04% | +28.6% |
| Q3 2016 | $70,000 | +59.1% | 1,900 | 0.0% | 0.04% | +52.2% |
| Q2 2016 | $44,000 | -42.9% | 1,900 | 0.0% | 0.02% | -46.5% |
| Q1 2016 | $77,000 | -34.7% | 1,900 | 0.0% | 0.04% | -33.8% |
| Q4 2015 | $118,000 | – | 1,900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |